JDRF Blog

JDRF Top Advances Over the Past Year

Thanks to the efforts of our donors and volunteers, we have made a series of top advances in our fight to cure...

Read More About JDRF Top Advances Over the Past Year

Celebrities Connect with Youth at the Children’s Congress 2019

“When your sugar is low, do you have trouble remembering your lines?”  “How do you keep your devices on when you are...

Read More About Celebrities Connect with Youth at the Children’s Congress 2019

JDRF Research Strategy: Cures and Improving Lives

They shared new developments and applauded the speed of scientific advancements. At this year’s Strategic Research Session, the tone was dynamic as...

Read More About JDRF Research Strategy: Cures and Improving Lives

JDRF Urges Congress to Fund Diabetes Research

On June 4, JDRF’s President & CEO Aaron J. Kowalski, Ph.D., testified before the U.S. House of Representatives Committee on Energy &...

Read More About JDRF Urges Congress to Fund Diabetes Research

Recent Articles

  • JDRF Research Strategy: Cures and Improving Lives

    May 31, 2019

    They shared new developments and applauded the speed of scientific advancements. At this year’s Strategic Research Session, the tone was dynamic as...

    Read more

  • The 20th Anniversary of the Edmonton Protocol

    March 11, 2019

    This day, 20 years ago, a person with type 1 diabetes (T1D) was cured. Well, pseudo-cured. On March 11, 1999, the Edmonton...

    Read more

  • Educators Align at the American Association of Diabetes Educators (AADE) Conference

    August 15, 2019

    Read more

  • October 2019 JDRF Young Adult Conference Speakers Announced

    August 13, 2019

    Read more

  • JDRF Hosts 3D Bioprinting Workshop for Type 1 Diabetes

    August 12, 2019

    “The final results should be more mature ‘cellular products’ for beta cell replacement as a functional cure for T1D.” Francesca Spagnoli, Ph.D.,...

    Read more

  • Gather your T1D-specific back to school resources

    August 12, 2019

    Read more

  • Triple Therapy in T1D: JDRF Researchers Launch a Clinical Trial

    August 12, 2019

    Read more

  • Summer Internship Experience at JDRF

    August 6, 2019

    Read more

  • FDA Breakthrough Therapy Designation for Teplizumab—Based on the First Study to Delay the Onset of T1D for 2+ Years

    August 5, 2019

    The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to teplizumab, an anti-CD3 monoclonal antibody, for the prevention or delay...

    Read more

  • FDA Approves the First Low Blood Sugar Treatment WITHOUT an Injection

    July 25, 2019

    Type 1 diabetes (T1D) can bring the fear of developing low blood sugar, called hypoglycemia, which can arise if someone takes too...

    Read more